SCHEMBL7265231

SCHEMBL7265231

CCc1[nH]c(=O)n(C(=O)C(C)c2ccccc2)c1C(=O)c1ccc(-n2ccnc2C)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 12/20 0.57
▸ PDE4B Q07343 12/20 0.57
▸ PDE4C Q08493 12/20 0.57
▸ PDE4D Q08499 12/20 0.57
▸ PDE3B Q13370 1/20 0.57
▸ PDE3A Q14432 1/20 0.57
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ PORCN Q9H237 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.34
▸ NR3C2 P08235 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7265112 0.89 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265692 0.86 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265073 0.86 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265164 0.84 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265330 0.84 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7271809 0.84 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265108 0.83 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265067 0.81 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265223 0.79 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7265292 0.78 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0264729-B1 Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)-benzoyl]]-2H-imidazol-one BERLEX LABORATORIES, INC. (US) 1992-03-25 — — EP claimed
US-4743612-A Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure BERLEX LABORATORIES, INC. (US) 1988-05-10 — — US claimed
EP-0264729-B1 Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)-benzoyl]]-2H-imidazol-one BERLEX LABORATORIES, INC. (US) 1992-03-25 — — EP disclosed
US-4743612-A Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure BERLEX LABORATORIES, INC. (US) 1988-05-10 — — US disclosed
Send feedback